News

The Current State of Cancer Care and Radiotherapy in the US
Cancer care and radiotherapy in the US continue to face sustained demand as cancer incidence remains high across the population. According to the American Cancer…
MVision AI’s Workspace+ Receives TGA Approval in Australia
Helsinki, February 2026 — MVision AI has received market approval from the Therapeutic Goods Administration (TGA) in Australia for Workspace+, its AI-powered platform for radiotherapy.…
MVision AI’s Workspace+ Available for Use in New Zealand
Helsinki, January 2026 — MVision AI today announced that Workspace+ is available for use in New Zealand following notification in the Web-Assisted Notification of Devices…
MVision AI’s Workspace+ Receives CE Mark Class IIa Certification
Helsinki, October 21, 2025 – MVision AI, a leading provider of vendor-neutral AI solutions for radiotherapy, proudly announces that its Workspace+ platform has received CE…
MVision AI Appoints Rachel Buckingham as Customer Success Manager
Helsinki, October 2025 – MVision AI is pleased to announce the appointment of Rachel Buckingham as Customer Success Manager, strengthening our customer partnerships and support…
MVision AI Working on Agreement to Offer Contour+ Access™ with Philips CT Simulators
Helsinki — September 28, 2025 — MVision AI today announced that it is working with Royal Philips on an agreement to offer MVision AI’s Contour+…
MVision AI Founder Mahmudul Hasan Returns as CEO to Lead Next Phase of Growth
Helsinki, September 2025 – MVision AI, a pioneer in AI solutions for radiotherapy, today announced that Mahmudul Hasan, the company’s Founder and Executive Director, is…
MVision AI Announces Distribution Partnership with Meditest in France
Helsinki, September 2025 — MVision AI, a global provider of AI-powered solutions for radiotherapy planning, has signed a distribution agreement with Meditest, a French specialist…
MVision AI’s Dose+ Receives Market Approval in Australia
Helsinki, August 2025 — MVision AI announces that Dose+ has received market approval for the Australian market from the Therapeutic Goods Administration (TGA). The product…
MVision AI’s Contour+ Approved for Clinical Use in Singapore
Helsinki, May 2025 — MVision AI announces that Contour+, its AI-based auto-contouring software for radiation therapy, has received market approval for clinical use in Singapore.…